查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511796

基于透明质酸的真皮填充剂市场规模、份额和趋势分析报告：按应用、按产品、按地区和细分市场预测，2024-2030 年

Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

基于透明质酸的真皮填充剂市场成长与趋势：

根据Grand View Research, Inc.最新报告预测，到2030年，全球透明质酸皮下填充剂市场规模预计将达到82.4亿美元，2024年至2030年复合年增长率为10.5%。

对微创手术的需求不断增加、老年人口不断增加、对年轻皮肤的认识和兴趣不断增强以及技术进步是推动市场成长的关键因素。

全球人口老化正在加剧。到2030年，全球六分之一的人将超过60岁，老年人口将从11亿增加到14亿。在美国，预计到2060年，四分之一的人口将年龄在65岁或以上。目前，世界60岁及以上人口三分之二生活在中等收入国家，中等收入国家正在发生重大变化。

然而，高昂的市场成本限制了市场机会。基于 HA 的真皮填充剂有 1 毫升注射器可供选择，每个注射器的价格为 600-1,000 美元。大多数情况下，至少需要2个注射器，治疗费用相当高，达到1600-2000美元。产品成本高昂，让低收入和中等收入国家的人难以负担。

基于透明质酸的真皮填充剂市场报告亮点

  • 单相产品细分市场占最大收益占有率，2023 年为 54.76%。
  • 从应用来看，除皱领域以2023年最大的销售份额29.53%引领市场。这是由于整容手术支出的增加以及使用透明质酸填充剂的除皱技术的出现。除皱是最常见的皮肤问题，导致该领域的需求增加。
  • 北美以 2023 年最大的销售份额主导市场。例如，根据加拿大统计局2021年9月发布的人口统计数据，加拿大60岁及以上的人口总数为96,88,677人。
  • 由于日本、中国和韩国等国家经济的快速成长以及该地区医疗基础设施的改善，预计亚太市场在预测期内将以最快的复合年增长率成长。
  • 艾尔建（AbbVie）是全球市场的主要企业之一。这是由于该公司基于 HA 的真皮填充剂 Juvederm 的长期市场占有率以及儘管推出了新产品但该产品的高性能。该公司拥有强大的透明质酸真皮填充剂产品系列，致力于将创新产品推向市场。

目录

第一章基于透明质酸的真皮填充剂市场：调查方法和范围

第二章基于透明质酸的真皮填充剂市场：执行摘要

  • 市场展望
  • 分部展望
  • 竞争考察

第三章以透明质酸为基础的真皮填充剂市场：变数、趋势、范围

  • 市场体系展望
  • 市场动态
  • 商业环境分析工具
  • 定性分析：COVID-19 对透明质酸真皮填充剂市场的影响

第四章 透明质酸真皮填充剂市场：产品评估与趋势分析

  • 基于透明质酸的真皮填充剂市场：产品仪表板
  • 基于透明质酸的真皮填充剂市场：产品变化分析
  • 2018-2030年基于玻尿酸的真皮填充剂市场规模、预测与趋势分析（依产品）
  • 单相产品
  • 双相产品

第五章 透明质酸真皮填充剂市场：应用估算与趋势分析

  • 基于透明质酸的真皮填充剂市场：应用仪表板
  • 透明质酸真皮填充剂市场：应用变化分析
  • 2018-2030年基于玻尿酸的真皮填充剂市场规模、预测与趋势分析（依应用）
  • 除皱
  • 丰唇术
  • 鼻整形术
  • 其他的

第六章基于透明质酸的真皮填充剂市场：区域估计和趋势分析

  • 基于透明质酸的真皮填充剂市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • Key company market share analysis, 2023
    • Allergan;Galderma Laboratories
    • Merz Pharmaceuticals
    • Genzyme Corporation
    • Anika Therapeutics Inc.
    • LG Life Sciences
    • LTD（LG Chem）
    • Bio plus Co. Ltd.
    • Sculpt Luxury
    • Dermal Fillers Ltd.
    • Bioxis Pharmaceutical
    • Sinclair Pharma;Laboratories
    • Vivacy;Bohus Biotech AB
Product Code: GVR-2-68038-999-9

Hyaluronic Acid-based Dermal Fillers Market Growth & Trends:

The global hyaluronic acid-based dermal fillers market size is anticipated to reach at USD 8.24 billion by 2030 and is projected to grow at a CAGR of 10.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. The increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are key factors driving the market growth.

The global ageing population is increasing. By 2030, 1 in 6 persons globally will be above 60 years old or over with total elder population growing from one 1 to 1.4 billion. In the U.S., it is estimated that one fourth of the people will be above 65 by 2060. Currently the middle-income countries are witnessing huge change with two-thirds of global population over 60 years would be from middle-income countries.

However, the higher cost of market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.

Hyaluronic Acid-based Dermal Fillers Market Report Highlights:

  • The single-phase products segment held the market with the largest revenue share of 54.76% in 2023, owing to the benefits like better effectiveness & offered by these products
  • Based on application, the wrinkle removal segment led the market with the largest revenue share of 29.53% in 2023. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for Wrinkle Removal suing HA-based fillers. Wrinkle Removal is the most common skin problems, resulting higher demand for the segment
  • North America dominated the market with the largest revenue share of in 2023. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and an growing ageing population in the region For instance, as per the Statistics Canada's population statistics published in September 2021, the total population above 60 years of age in Canada is 96, 88,677
  • The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region
  • Allergan (AbbVie), is a one of the major global market leaders. This can be attributed to market presence of Juvederm, a HA based dermal filler by the company for long time and better performance of product despite new products being introduced. The company's has powerful product portfolio of HA based dermal fillers & focuses on introducing innovative products into in market

Table of Contents

Chapter 1 Hyaluronic Acid-based Dermal Fillers Market: Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Application
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3

Chapter 2 Hyaluronic Acid-based Dermal Fillers Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Product
    • 2.2.2 Application
    • 2.2.3 Region
  • 2.3 Competitive Insights

Chapter 3 Hyaluronic Acid-based Dermal Fillers Market: Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Growing Aging Population
      • 3.2.1.2 Increasing Awareness and Acceptance of Aesthetic Treatments
      • 3.2.1.3 Technological Advancements
    • 3.2.2 Market Restraint Analysis
    • 3.2.3 Regulatory Contraints
    • 3.2.4 High Cost of Procedures
  • 3.3 Business Environment Analysis Tools
    • 3.3.1 Porter's five forces analysis
      • 3.3.1.1 Bargaining power of buyers: Low
      • 3.3.1.2 Bargaining power of suppliers: Moderate
      • 3.3.1.3 Competitive Rivalry: High
      • 3.3.1.4 Threat of new entrants: Moderate
      • 3.3.1.5 Threat of substitutes: Low
    • 3.3.2 SWOT Analysis, by PESTEL
      • 3.3.2.1 Political & legal
      • 3.3.2.2 Economic
      • 3.3.2.3 Technological
  • 3.4 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market

Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis

  • 4.1. Hyaluronic Acid-based Dermal Fillers Market: Product Dashboard
  • 4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
  • 4.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Single-Phase Product
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Duplex Product
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis

  • 5.1. Hyaluronic Acid-based Dermal Fillers Market: Application Dashboard
  • 5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
  • 5.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Wrinkle Removal
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Lip Augmentation
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Rhinoplasty
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Country, Type & Therapy

  • 6.1. Hyaluronic Acid-based Dermal Fillers Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2023
    • 7.3.2. Allergan; Galderma Laboratories
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Type benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Merz Pharmaceuticals
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Type benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Genzyme Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Anika Therapeutics Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. LG Life Sciences
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. LTD (LG Chem)
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Bio plus Co. Ltd.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Sculpt Luxury
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Dermal Fillers Ltd.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Bioxis Pharmaceutical
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Sinclair Pharma; Laboratories
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Vivacy; Bohus Biotech AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Hyaluronic acid-based dermal fillers market segmentation
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Hyaluronic acid-based dermal fillers product market share analysis, 2023 & 2030
  • Fig. 14 Hyaluronic acid-based dermal fillers product market: Segment dashboard
  • Fig. 15 Single-phase product market estimates and forecast, 2018 - 2030
  • Fig. 16 Duplex product market estimates and forecast, 2018 - 2030
  • Fig. 17 Hyaluronic acid-based dermal fillers application market share analysis, 2023 & 2030
  • Fig. 18 Hyaluronic acid-based dermal fillers application market: Segment dashboard
  • Fig. 19 Wrinkle removal market estimates and forecasts, 2018 - 2030
  • Fig. 20 Lip augmentation market estimates and forecasts,2018 - 2030
  • Fig. 21 Rhinoplasty market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Hyaluronic acid-based dermal fillers regional market share analysis, 2023 & 2030
  • Fig. 24 Hyaluronic acid-based dermal fillers regional market: Segment dashboard
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Company market position analysis.